Hu, Jiankang
408  results:
Search for persons X
?
1

Safety and efficacy of peficitinib in Asian patients with r..:

Yang, Yue ; Li, Jingyang ; Liu, Ju...
The Lancet Regional Health - Western Pacific.  42 (2024)  - p. 100925 , 2024
 
?
3

Discovery of a Promising CBP/p300 Degrader XYD129 for the T..:

Wu, Tianbang ; Hu, Jiankang ; Zhao, Xiaofan...
Journal of Medicinal Chemistry.  67 (2024)  11 - p. 9194-9213 , 2024
 
?
4

CBP/p300 Degrader: A Promising Therapeutic Strategy for Tre..:

Hu, Jiankang ; Xu, Yong
Journal of Medicinal Chemistry.  67 (2024)  7 - p. 5272-5274 , 2024
 
?
6

Discovery of Highly Potent and Efficient CBP/p300 Degraders..:

Hu, Jiankang ; Xu, Hongrui ; Wu, Tianbang...
Journal of Medicinal Chemistry.  67 (2024)  9 - p. 6952-6986 , 2024
 
?
7

Telitacicept in patients with active systemic lupus erythem..:

Wu, Di ; Li, Jing ; Xu, Dong...
Annals of the Rheumatic Diseases.  83 (2023)  4 - p. 475-487 , 2023
 
?
10

Efficacy and Safety of CMAB008 Compared with Innovator Infl..:

Ye, Hua ; Liu, Shengyun ; Xu, Jian...
Rheumatology and Therapy.  10 (2023)  3 - p. 757-773 , 2023
 
?
12

Structural insights revealed by the cocrystal structure of ..:

Xu, Hongrui ; Luo, Guolong ; Wu, Tianbang...
Biochemical and Biophysical Research Communications.  623 (2022)  - p. 17-22 , 2022
 
?
 
?
14

Discovery, optimization and evaluation of 1-(indolin-1-yl)e..:

Xiang, Qiuping ; Luo, Guolong ; Zhang, Cheng...
European Journal of Medicinal Chemistry.  236 (2022)  - p. 114311 , 2022
 
?
15

Design, Synthesis, and Biological Evaluation of 1-(Indolizi..:

Xiang, Qiuping ; Wang, Chao ; Wu, Tianbang...
Journal of Medicinal Chemistry.  65 (2021)  1 - p. 785-810 , 2021
 
1-15